Clinical trials
Recruiting Phase 1/2 Glioma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| AstraZeneca | 1 |
| Centre Leon Berard | 1 |
| Cerenome | 1 |
| Chirag G. Patil | 1 |
| Essen Biotech | 1 |
| Fundación de investigación HM | 1 |
| Hangzhou Hanx Biopharmaceuticals, Ltd. | 1 |
| ImmVira Pharma Co. Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 21 |
| Glioblastoma | 9 |
| Brain Neoplasms | 8 |
| Central Nervous System Neoplasms | 5 |
| Recurrence | 4 |
| Ependymoma | 3 |
| Medulloblastoma | 3 |
| Meningioma | 3 |
| Astrocytoma | 2 |
| Neoplasms | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.